NewAmsterdam Pharma Company N.V. (NAMS) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$28.46
-1.18%
Mkt Cap $3.42B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 18, 2026 | $1.25M | $32.00K | -97.44% | -$0.40 | -$0.63 | -57.50% | — | — |
| Q4 2025 Nov 5, 2025 | $2.40M | $348.00K | -85.50% | -$0.38 | -$0.41 | -7.89% | — | — |
| Q3 2025 Aug 6, 2025 | $3.49M | $22.43M | +541.97% | -$0.52 | -$0.15 | +71.15% | — | — |
| Q2 2025 May 8, 2025 | $1.46M | $3.22M | +121.07% | -$0.45 | -$0.49 | -8.89% | — | — |
| Q1 2025 Feb 26, 2025 | $1.76M | $13.23M | +653.31% | -$0.48 | -$0.95 | -97.92% | — | — |
| Q4 2024 Nov 6, 2024 | $1.87M | $32.52M | +1636.95% | -$0.48 | -$0.18 | +62.50% | — | — |
| Q3 2024 Aug 7, 2024 | $1.21M | $2.45M | +103.18% | -$0.59 | -$0.51 | +13.56% | — | — |
| Q2 2024 May 8, 2024 | $1.62M | $1.51M | -7.03% | -$0.54 | -$0.62 | -14.81% | — | — |
| Q1 2024 Mar 29, 2024 | — | $1.75M | — | -$0.60 | -$0.57 | +5.46% | — | — |
| Q1 2024 Feb 28, 2024 | — | $1.98M | — | -$0.55 | -$0.54 | +1.82% | — | — |
| Q3 2023 Aug 7, 2023 | — | $1.72M | — | -$0.39 | -$0.47 | -19.92% | — | — |
| Q2 2023 Jun 30, 2023 | — | $8.65M | — | -$0.44 | -$0.52 | -17.25% | — | — |
| Q1 2023 Mar 31, 2023 | — | $1.49M | — | -$0.61 | -$2.37 | -289.04% | — | — |
| Q4 2022 Oct 18, 2022 | — | $5.49M | — | — | -$2.14 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | $48.90M | — | — | $1.61 | — | — | — |
| Q1 2022 Mar 30, 2022 | — | $51.71M | — | — | $1.70 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$1.13 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$0.63 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.32 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.31 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | $0.00 | — | — | — |
| Q3 2020 Sep 30, 2020 | — | — | — | — | -$0.02 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$0.02 | — | — | — |
| Q1 2020 Mar 31, 2020 | — | — | — | — | -$0.02 | — | — | — |